arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Vor Biopharma Inc.

VOR Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$18.43
▼ -2.7% Today
as of Oct 23, 09:53 ET
Last 30 days -20.58% Sep 14 → Oct 23
$17.63 $19.09 $20.56 $22.02 $23.48 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$18.87
High
$19.38
Low
$18.66
Volume
$722,255
Avg Vol
$1M
Mkt Cap
$1.1B
P/E (TTM)
—
Beta
—
52w High
$28.66
52w Low
$6.50
Div Yield
—
Shares Out
$54M

Recent Press Releases & News last 60 days · 8 items

Oct 21 · 11:42 MT Newswires
William Blair Initiates Vor Biopharma at Outperform
Oct 8 · 15:17 Simply Wall St.
Vor Biopharma (VOR) Could Be 52% Undervalued As Phase 3 gMG Data Draw Focus
Oct 5 · 22:00 PR GlobeNewswire
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
▸ Show all 8 press releases & news Free account →

VOR earnings at a glance

The options market is pricing a move of about ±16.7% after the report, a range of roughly $15.35 to $21.51 from today's $18.43. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±5.1% on average; after the most recent report on May 13, 2026 it moved -3.4%. That means options currently expect more movement than VOR has typically delivered. VOR beat the consensus EPS estimate in 1 of its last 4 reported quarters. Implied volatility is currently 142%. The share price of $18.43 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$6.50
$29
54% of range
Avg surprise (last 4)
-73.2%
Avg reaction (last 2)
+1.7%
50% positive
Latest IV / EM
142%
EM ±16.7% · $20 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-8.05$-6.10$-4.15$-2.20$-0.25 Actual $-0.43Actual $-0.45Actual $-0.49Actual $-0.45Actual $-0.41Actual $-8.05Actual $-0.26Est $-0.25Actual $-2.18Est $-0.57Actual $-3.33Est $-3.06Actual $-0.73Est $-0.75Actual $-1.16 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-1.6B$-1.2B$-801M$-415M$-29M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-1.16 — — — — financials
Wed May 13, 2026Mar/2026 $-0.73 $-0.75 +2.7% -180.8% -3.4% earnings
Thu Nov 13, 2025Sep/2025 $-3.33 $-3.06 -8.8% — — earnings
Tue Aug 12, 2025Jun/2025 $-2.18 $-0.57 -282.5% — — earnings
Wed May 14, 2025Mar/2025 $-0.26 $-0.25 -4.0% — +6.9% earnings
Mon Sep 30, 2024Sep 2024 $-8.05 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.41 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.45 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.49 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.45 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.43 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-48M$-35M—$-28M$-274M$-33M—$-29M
Net income$-63M$-220M—$-813M$-1.57B$-32M—$-28M
EPS (diluted)$-1.16$-5.11—$-121.63$-251.24$-5.21—$-8.05

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$108M$170M$396M$160M$191M$50M$82M$53M
Inventory————————
Total current assets$475M$501M$458M$172M$205M$65M$97M$67M
Total assets$481M$507M$464M$176M$205M$109M$143M$116M
Long-term debt————————
Total liabilities$681M$657M$628M$2.40B$1.71B$43M$46M$43M
Total equity$-200M$-150M$-164M$-2.23B$-1.51B$66M$-97M$73M

Implied volatility — last 90 days

59%129%198%268%337% Jul 22 — IV 137% · EM ±31.3%Jul 23 — IV 145% · EM ±32.7%Jul 24 — IV 141% · EM ±31.1%Jul 27 — IV 135% · EM ±28.3%Jul 28 — IV 134% · EM ±27.5%Jul 29 — IV 133% · EM ±26.6%Jul 30 — IV 162% · EM ±31.7%Jul 31 — IV 133% · EM ±25.4%Aug 03 — IV 168% · EM ±29.7%Aug 04 — IV 137% · EM ±23.6%Aug 05 — IV 136% · EM ±22.8%Aug 06 — IV 140% · EM ±22.6%Aug 07 — IV 164% · EM ±25.6%Aug 10 — IV 134% · EM ±18.6%Aug 11 — IV 166% · EM ±22.0%Aug 12 — IV 129% · EM ±16.1%Aug 13 — IV 129% · EM ±15.2%Aug 14 — IV 147% · EM ±16.3%Aug 17 — IV 116% · EM ±9.7%Aug 18 — IV 114% · EM ±8.3%Aug 19 — IV 69% · EM ±4.1%Aug 24 — IV 75% · EM ±15.6%Aug 25 — IV 116% · EM ±23.7%Aug 26 — IV 79% · EM ±15.8%Aug 27 — IV 85% · EM ±16.6%Aug 28 — IV 60% · EM ±11.5%Aug 31 — IV 76% · EM ±13.5%Sep 01 — IV 95% · EM ±16.3%Sep 02 — IV 114% · EM ±19.0%Sep 03 — IV 145% · EM ±23.4%Sep 04 — IV 135% · EM ±21.2%Sep 07 — IV 153% · EM ±21.2%Sep 08 — IV 62% · EM ±8.2%Sep 09 — IV 86% · EM ±10.8%Sep 10 — IV 80% · EM ±9.4%Sep 14 — IV 275% · EM ±23.0%Sep 15 — IV 338% · EM ±24.4%Sep 16 — IV 224% · EM ±13.2%Sep 17 — IV 309% · EM ±12.9%Sep 21 — IV 116% · EM ±24.2%Sep 22 — IV 80% · EM ±16.4%Sep 23 — IV 120% · EM ±24.1%Sep 24 — IV 138% · EM ±27.1%Sep 25 — IV 144% · EM ±27.5%Sep 28 — IV 197% · EM ±35.0%Sep 29 — IV 168% · EM ±28.9%Sep 30 — IV 149% · EM ±24.9%Oct 01 — IV 187% · EM ±30.3%Oct 02 — IV 192% · EM ±30.0%Oct 06 — IV 165% · EM ±21.8%Oct 07 — IV 178% · EM ±22.4%Oct 08 — IV 142% · EM ±16.7%

Sector peers

MGTX
MeiraGTx Holdings plc
$1.0B $9.37-5.0%
CGEM
Cullinan Therapeutics, Inc.
$1.0B $14.01-5.9%
IMTX
Immatics N.V.
$1.1B $7.36-4.3%
REPL
Replimune Group, Inc.
$1.2B $11.61-0.9%
GLUE
Monte Rosa Therapeutics, Inc.
$868M $10.75-4.2%
SANA
Sana Biotechnology, Inc.
$814M $2.29-2.8%

VOR earnings FAQ

What is VOR's expected move for earnings?

Options currently price a move of about ±16.7%, or $3.08 per share either way from $18.43.

How does VOR stock usually react to earnings?

Across the last 2 reports the average next-day move was ±5.1%, up 1 times and down 1 times.

What is VOR's implied volatility?

VOR's at-the-money implied volatility is about 142% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in